Published in J Virol on May 01, 2000
Covalent modifications of the ebola virus glycoprotein. J Virol (2002) 2.84
Comprehensive analysis of ebola virus GP1 in viral entry. J Virol (2005) 2.56
Tyro3 family-mediated cell entry of Ebola and Marburg viruses. J Virol (2006) 2.24
Altering the tropism of lentiviral vectors through pseudotyping. Curr Gene Ther (2005) 2.21
Proteolysis of the Ebola virus glycoproteins enhances virus binding and infectivity. J Virol (2007) 2.16
Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol (2003) 2.11
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics. J Virol (2004) 2.09
Association of the caveola vesicular system with cellular entry by filoviruses. J Virol (2002) 1.72
Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J Virol (2001) 1.65
Biochemical and functional characterization of the Ebola virus VP24 protein: implications for a role in virus assembly and budding. J Virol (2003) 1.60
Emerging targets and novel approaches to Ebola virus prophylaxis and treatment. BioDrugs (2013) 1.57
Ebolavirus glycoprotein structure and mechanism of entry. Future Virol (2009) 1.56
Forty-five years of Marburg virus research. Viruses (2012) 1.34
Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol J (2009) 1.33
Transduction of bone-marrow-derived mesenchymal stem cells by using lentivirus vectors pseudotyped with modified RD114 envelope glycoproteins. J Virol (2004) 1.31
Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors. J Virol (2009) 1.20
Filovirus tropism: cellular molecules for viral entry. Front Microbiol (2012) 1.18
Endogenous CD317/Tetherin limits replication of HIV-1 and murine leukemia virus in rodent cells and is resistant to antagonists from primate viruses. J Virol (2010) 1.17
In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River Virus glycoproteins. J Virol (2002) 1.16
Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition. Cell Microbiol (2009) 1.16
The ERK mitogen-activated protein kinase pathway contributes to Ebola virus glycoprotein-induced cytotoxicity. J Virol (2006) 1.15
Antibody-mediated neutralization of Ebola virus can occur by two distinct mechanisms. Virology (2010) 1.09
Filovirus entry: a novelty in the viral fusion world. Viruses (2012) 1.03
Mannosyl glycodendritic structure inhibits DC-SIGN-mediated Ebola virus infection in cis and in trans. Antimicrob Agents Chemother (2003) 1.02
Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry. J Virol (2011) 1.01
Discovery, synthesis, and biological evaluation of a novel group of selective inhibitors of filoviral entry. J Med Chem (2011) 0.95
Anti-HIV activity mediated by natural killer and CD8+ cells after toll-like receptor 7/8 triggering. PLoS One (2008) 0.94
Host cell factors in filovirus entry: novel players, new insights. Viruses (2012) 0.91
Triggering TLR2, -3, -4, -5, and -8 reinforces the restrictive nature of M1- and M2-polarized macrophages to HIV. J Virol (2014) 0.88
A functional henipavirus envelope glycoprotein pseudotyped lentivirus assay system. Virol J (2010) 0.86
A comparative high-throughput screening protocol to identify entry inhibitors of enveloped viruses. J Biomol Screen (2013) 0.86
Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors. Retrovirology (2010) 0.85
Function of membrane rafts in viral lifecycles and host cellular response. Biochem Res Int (2011) 0.82
sGP serves as a structural protein in Ebola virus infection. J Infect Dis (2011) 0.80
Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling. Bioeng Bugs (2011) 0.78
Diverse viral glycoproteins as well as CD4 co-package into the same human immunodeficiency virus (HIV-1) particles. Retrovirology (2014) 0.77
A parallel genome-wide RNAi screening strategy to identify host proteins important for entry of Marburg virus and H5N1 influenza virus. Virol J (2015) 0.77
Chemically Modified Human Serum Albumin Potently Blocks Entry of Ebola Pseudoviruses and Viruslike Particles. Antimicrob Agents Chemother (2017) 0.75
Ebola virus mediated infectivity is restricted in canine and feline cells. Vet Microbiol (2015) 0.75
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
Fcγ-receptor IIa-mediated Src Signaling Pathway is Essential for the Antibody-Dependent Enhancement of Ebola Virus Infection. PLoS Pathog (2016) 0.75
A Bioluminescent Imaging Mouse Model for Marburg Virus Based on a Pseudovirus system. Hum Vaccin Immunother (2017) 0.75
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology (1995) 14.30
The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02
A system for functional analysis of Ebola virus glycoprotein. Proc Natl Acad Sci U S A (1997) 6.86
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 5.16
Pseudotyping with human T-cell leukemia virus type I broadens the human immunodeficiency virus host range. J Virol (1991) 4.74
Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain. Mol Cell (1998) 4.73
Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33
Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24
Sequence analysis of the Ebola virus genome: organization, genetic elements, and comparison with the genome of Marburg virus. Virus Res (1993) 3.89
Core structure of the envelope glycoprotein GP2 from Ebola virus at 1.9-A resolution. Proc Natl Acad Sci U S A (1999) 3.23
Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science (1989) 2.77
Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell (1983) 2.11
Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J Virol (1998) 2.03
Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein. J Virol (1993) 1.85
V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J Virol (1999) 1.49
Variation in the glycoprotein and VP35 genes of Marburg virus strains. Virology (1998) 1.45
The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elements. J Biol Chem (1994) 1.05
[The penetration of the Marburg virus into eukaryotic cells]. Vopr Virusol (1994) 0.90
Multiple extracellular elements of CCR5 and HIV-1 entry: dissociation from response to chemokines. Science (1996) 3.84
Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop. J Virol (1997) 3.44
HIV-1 actively replicates in naive CD4(+) T cells residing within human lymphoid tissues. Immunity (2001) 3.43
Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 2.39
An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nat Struct Biol (1998) 2.24
A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem (1997) 2.00
Molecular uncoupling of C-C chemokine receptor 5-induced chemotaxis and signal transduction from HIV-1 coreceptor activity. Proc Natl Acad Sci U S A (1997) 1.91
CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissue. Proc Natl Acad Sci U S A (1999) 1.67
Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol (2000) 1.62
The CD2 ligand LFA-3 activates T cells but depends on the expression and function of the antigen receptor. J Immunol (1988) 1.49
V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1. J Virol (1999) 1.49
HIV-1 Vpr enhances viral burden by facilitating infection of tissue macrophages but not nondividing CD4+ T cells. J Exp Med (2001) 1.45
De novo demonstration and co-localization of free-radical production and apoptosis formation in rat kidney subjected to ischemia/reperfusion. J Am Soc Nephrol (2001) 1.39
Human immunodeficiency virus type 1 coreceptor preferences determine target T-cell depletion and cellular tropism in human lymphoid tissue. J Virol (2000) 1.39
JAK/STAT signaling by cytokine receptors. Curr Opin Immunol (1998) 1.36
Susceptibility of rat-derived cells to replication by human immunodeficiency virus type 1. J Virol (2001) 1.33
Quantitative prediction of drug toxicity in humans from toxicology in small and large animals. Cancer Res (1975) 1.22
Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylation. Curr Biol (1997) 1.16
Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity. Proc Natl Acad Sci U S A (1995) 1.16
Viral entry through CXCR4 is a pathogenic factor and therapeutic target in human immunodeficiency virus type 1 disease. J Virol (2000) 1.10
Cytopathicity of human immunodeficiency virus type 1 primary isolates depends on coreceptor usage and not patient disease status. J Virol (2001) 1.10
A trans-receptor mechanism for infection of CD4-negative cells by human immunodeficiency virus type 1. Curr Biol (1999) 1.07
The molecular role of the common gamma c subunit in signal transduction reveals functional asymmetry within multimeric cytokine receptor complexes. Proc Natl Acad Sci U S A (1996) 1.06
Retrospective analysis of varicella zoster virus (VZV) copy DNA numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients. Transpl Infect Dis (2006) 1.04
Cytopathicity of human immunodeficiency virus type 2 (HIV-2) in human lymphoid tissue is coreceptor dependent and comparable to that of HIV-1. J Virol (2000) 1.04
Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection. J Virol (1998) 1.02
Reduction in lipopolysaccharide-induced thrombocytopenia by triflavin in a rat model of septicemia. Circulation (1999) 1.00
Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosis. J Biol Chem (1998) 0.99
Distinct tyrosine residues within the interleukin-2 receptor beta chain drive signal transduction specificity, redundancy, and diversity. J Biol Chem (1996) 0.97
Shared gamma(c) subunit within the human interleukin-7 receptor complex. A molecular basis for the pathogenesis of X-linked severe combined immunodeficiency. J Clin Invest (1997) 0.95
Parallel evolution of CCR5-null phenotypes in humans and in a natural host of simian immunodeficiency virus. Curr Biol (1998) 0.95
Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J (1996) 0.92
Isolation and identification of a new diuretic peptide from the tobacco hornworm, Manduca sexta. Biochem Biophys Res Commun (1991) 0.92
Combination chemotherapy of advanced Hodgkin's disease. A review. Cancer (1974) 0.91
Redundant and selective roles for erythropoietin receptor tyrosines in erythropoiesis in vivo. Blood (1998) 0.91
Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus. J Clin Endocrinol Metab (1994) 0.90
A study on the prevalence of and risk factors for neck pain in secondary school teachers. Public Health (2006) 0.90
Further observations on four subgroups of normal variant short stature. J Clin Endocrinol Metab (1980) 0.89
Shared and unique determinants of the erythropoietin (EPO) receptor are important for binding EPO and EPO mimetic peptide. J Biol Chem (1999) 0.89
Oligomerization and scaffolding functions of the erythropoietin receptor cytoplasmic tail. J Biol Chem (1999) 0.89
Methadone-induced Torsade de pointes after stopping lopinavir-ritonavir. Eur J Clin Microbiol Infect Dis (2007) 0.88
Primary and recombinant HIV type 1 strains resistant to protease inhibitors are pathogenic in mature human lymphoid tissues. AIDS Res Hum Retroviruses (2001) 0.88
Analysis of interleukin-2-dependent signal transduction through the Shc/Grb2 adapter pathway. Interleukin-2-dependent mitogenesis does not require Shc phosphorylation or receptor association. J Biol Chem (1995) 0.87
The integration of chemotherapy into a combined modality approached to cancer therapy. V. Squamous cell cancer of the head and neck. Cancer Treat Rev (1975) 0.86
TLR9 triggering in Burkitt's lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification. Oncogene (2010) 0.84
Predicting the response of growth hormone-deficient children to long term treatment with human growth hormone. J Clin Endocrinol Metab (1979) 0.84
A method of screening for growth hormone deficiency using anthropometrics. Am J Clin Nutr (1981) 0.83
Hepatic handling of bile salts and protein in the rat during intrahepatic cholestasis. Gastroenterology (1983) 0.83
Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer. Ann Thorac Surg (2001) 0.83
Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction. J Biol Chem (1995) 0.83
Human immunodeficiency virus type 1 clade A and D neurotropism: molecular evolution, recombination, and coreceptor use. Virology (2001) 0.83
Genetic evidence for an additional factor required for erythropoietin-induced signal transduction. Blood (1999) 0.82
Ligand-induced association between the T-cell antigen receptor and two glycoproteins. Proc Natl Acad Sci U S A (1989) 0.82
Alveolar echinococcosis of the liver in an adult with human immunodeficiency virus type-1 infection. Infection (2004) 0.81
Characterization of Anopheles pseudopunctipennis sensu lato from three countries of neotropical America from variation in allozymes and ribosomal DNA. Am J Trop Med Hyg (1993) 0.81
New clues about T-cell antigen receptor complex function. Immunol Today (1989) 0.81
Supplementation of N-acetylcysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res Hum Retroviruses (1995) 0.79
Human T cell development and HIV infection in human hemato-lymphoid system mice. Curr Top Microbiol Immunol (2008) 0.79
Impaired CD8+ T-cell reactivity against viral antigens in cancer patients with solid tumors. Infection (2004) 0.79
Gluconate calcium therapy and neonatal hypercalciuria. Am J Dis Child (1981) 0.78
The alpha chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding. Cytokine (1996) 0.77
Pharmacokinetics/pharmacodynamics of ketoconazole-prednisolone interaction. J Pharmacol Exp Ther (1992) 0.77
Failure of carnitine to prevent adriamycin cardiomyopathy. Cancer Treat Rep (1979) 0.76
Serum and urine polyamines in normal and in short children. J Clin Invest (1979) 0.76
[Genetic evidence of a species complex in Anopheles pseudopunctipennis pseudopunctipennis]. Bol Oficina Sanit Panam (1992) 0.76
Molecular function of the CD4 D1 domain in coreceptor-mediated entry by HIV type 1. AIDS Res Hum Retroviruses (2000) 0.76
Evidence through crossmating experiments of a species complex in Anopheles pseudopunctipennis sensu lato: a primary malaria vector of the American continent. Am J Trop Med Hyg (1993) 0.76
Genetic evidence of a species complex in Anopheles pseudopunctipennis sensu lato. Bull Pan Am Health Organ (1993) 0.76
[Glucocorticoids and infection]. Schweiz Med Wochenschr (1992) 0.76
The activation of T lymphocytes. Rheum Dis Clin North Am (1987) 0.75
CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesis. Clin Exp Immunol (2004) 0.75
Abnormal polyamine metabolism in hereditary muscular dystrophies: effect of human growth hormone. J Clin Invest (1980) 0.75
Impact of TNFalpha, LTalpha, Fc gammaRII and complement receptor on HIV-1 trapping in lymphoid tissue from HIV-infected patients. AIDS (2000) 0.75
Rapidly destructive Staphylococcus epidermidis endocarditis. Infection (2005) 0.75
Emergency defibrillation performed by coronary nursing staff: A pilot report. Hong Kong Med J (1998) 0.75
Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia. J Clin Endocrinol Metab (1989) 0.75
Phase I study of L-alanosine (NSC 15353). Cancer (1983) 0.75
Multistage evaluation scale, differential threshold steps and equivalent sensation contours of respiratory flow-resistive load sensation. Sci Sin B (1988) 0.75
Kaposi's sarcoma in a young homosexual man. Association with angiofollicular lymphoid hyperplasia and a malignant lymphoproliferative disorder. Arch Pathol Lab Med (1983) 0.75
Phase I study of m-AMSA in patients with solid tumors and leukemias. Cancer Clin Trials (1980) 0.75
Effects of combined resistive loading on the respiratory pattern and the subject's perception. Adv Exp Med Biol (1988) 0.75
A transfected human muscarinic receptor fails to substitute for the T cell antigen receptor complex in CD2-initiated signal transduction. Int Immunol (1990) 0.75
Phase I study of mitoxantrone on a daily X 5 schedule. Am J Clin Oncol (1984) 0.75
The linoleic acid requirement of the human infant [proceedings]. Proc Nutr Soc (1976) 0.75
Niacin in instant coffee. Proc Nutr Soc (1977) 0.75
Methylxanthine consumption from coffee and tea. Proc Nutr Soc (1975) 0.75
Prolonged chemotherapeutic remission of metastatic ovarian dysgerminoma. Report of a case. Gynecol Oncol (1977) 0.75
Renal calcification in premature infants. Pediatrics (1983) 0.75
Alterations in protein transport events in rat liver after estrogen treatment. Am J Physiol (1987) 0.75
Prolonged chemotherapeutic remission and possible cure of metastatic dysgerminoma. Gynecol Oncol (1987) 0.75
The vitamin E CONTENT OF SELECTED INFANT MILK FORMULAS. Proc Nutr Soc (1974) 0.75
Pharmacokinetics and chronic toxicity of cyclosporine A in genetic hydroxylation-deficient dark Agouti rats. J Pharmacokinet Biopharm (1990) 0.75
From the cell to the community: AIDS research in California. The University of California Universitywide AIDS Research Program annual meeting, February 2000. West J Med (2000) 0.75